U.S. flag

An official website of the United States government

PMC Full-Text Search Results

Items: 5

1.
Figure 3

Figure 3. From: The Bradykinin B1 Receptor Regulates Aβ Deposition and Neuroinflammation in Tg-SwDI Mice.

B1R blockade is not associated with changes in APP processing or in levels of LRP1, APOE, and neprilysin in Tg-SwDI mice. Representative blots (A) and quantitative results (B) of Western blot analysis showing that R715 administration (1 mg/kg, s.c., 8 weeks) causes no changes in the levels of APP, APP C-terminal fragments C99 and C83, or APP-cleaving enzymes BACE1, ADAM10, and ADAM17, compared with vehicle-treated animals. C and D: Effect of R715 treatment on the expression of LRP1, APOE, and neprilysin. GAPDH levels were used as loading controls. The values represent means ± SEM (N = 6 to 8).

Giselle F. Passos, et al. Am J Pathol. 2013 May;182(5):1740-1749.
2.
Figure 5

Figure 5. From: The Bradykinin B1 Receptor Regulates Aβ Deposition and Neuroinflammation in Tg-SwDI Mice.

B1R blockade reduces neuroinflammation in Tg-SwDI mice. Representative blots (A) and quantitative results (B) of Western blot analysis demonstrating that s.c. administration of 1 mg/kg R715 for 8 weeks reduces the levels of phosphorylated-p65 NF-κB, but not of liver X receptor, peroxisome proliferator-activated receptor γ, or matrix metalloproteinase (MMP)-9, compared with vehicle-treated mice. GAPDH levels were used as loading controls. C: Cytokine expression determined by a cytokine array. Data were quantified as pixel density and presented as percentage of vehicle-treated controls. The values represent means ± SEM (N = 4 to 8). *P < 0.05, **P < 0.01.

Giselle F. Passos, et al. Am J Pathol. 2013 May;182(5):1740-1749.
3.
Figure 4

Figure 4. From: The Bradykinin B1 Receptor Regulates Aβ Deposition and Neuroinflammation in Tg-SwDI Mice.

B1R blockade reduces glial cell activation in Tg-SwDI mice. A and B: Tg-SwDI mouse brains s.c. treated with 1 mg/kg R715 for 8 weeks exhibited a significant decrease in GFAP-positive astrocytes and CD68-, CD11b-, and CD45-positive microglia immunoreactivity versus vehicle-treated animals. Confocal analysis showing the colocalization of 6E10-positive Aβ deposits (red) and GFAP-positive astrocytes (green) (C) or Iba-1–positive microglia (green) (D). Representative photomicrographs were taken from the subiculum. Scale bars: 50 μm (GFAP and CD11b); 10 μm (CD45 and CD68); and 25 μm (C and D). The values represent means ± SEM (N = 5 to 6). **P < 0.01. The graph represents the average of inflammatory cells on the cortex, dentate gyrus, subiculum, and thalamus.

Giselle F. Passos, et al. Am J Pathol. 2013 May;182(5):1740-1749.
4.
Figure 2

Figure 2. From: The Bradykinin B1 Receptor Regulates Aβ Deposition and Neuroinflammation in Tg-SwDI Mice.

B1R up-regulation affects Aβ deposition in Tg-SwDI brain. Mice s.c. treated with 1 mg/kg R715 for 8 weeks have no changes in the levels of Aβ40 in the detergent-soluble fraction (A), whereas increased levels of Aβ40 were observed in the detergent-insoluble fraction (B), and both detergent-soluble (C) and detergent-insoluble (D) Aβ42 levels remained unchanged, as measured by ELISA. E and F: Aβ40 immunoreactivity was increased in cortex (Ctx), thalamus (Tha), hippocampus (Hip), dentate gyrus (DG), and subiculum (Sub) of R715-treated mice when compared with the vehicle-treated group. E and G: R715 administration had no effect on Aβ42 immunoreactivity in Tg-SwDI brains. Representative photomicrographs (H) and quantitative results (I) demonstrating increased thioflavin S–positive fibrillar Aβ deposits in R715-treated mice. Representative photomicrographs were taken from subiculum (E) and thalamus (H). Scale bars: 10 μm (E); 15 μm (H). The values represent means ± SEM (N = 5 to 6). *P < 0.05, **P < 0.01.

Giselle F. Passos, et al. Am J Pathol. 2013 May;182(5):1740-1749.
5.
Figure 1

Figure 1. From: The Bradykinin B1 Receptor Regulates Aβ Deposition and Neuroinflammation in Tg-SwDI Mice.

B1R is up-regulated in Tg-SwDI brain. Representative blots (A) and quantitative results (B) of Western blot analysis showing the increased expression of B1R in the brains of 10-month-old Tg-SwDI mice compared with age-matched nTg animals. GAPDH levels were used as loading controls. C: In nTg mice, confocal analysis demonstrated the colocalization of B1R (red) and NeuN-positive (green) neurons, and elevated immunoreactivities of B1R (red) colocalized with NeuN-positive neurons, collagen IV–positive vessels, and GFAP-positive astrocytes (all green) were observed in Tg-SwDI mice. Representative photomicrographs were taken from hippocampus (Hip; NeuN/B1R), dentate gyrus (GFAP/B1R), and thalamus (collagen IV/B1R). D: B1R immunoreactivity was increased in cortex (Ctx), thalamus (Tha), dentate gyrus (DG), and subiculum (Sub) of Tg-SwDI versus nTg mice. E: Confocal laser microscopy of B1R (red), tomato lectin (green), and 6E10 (blue) demonstrated the colocalization of the B1R and the vasculature in areas of Aβ deposits (6E10) in the brains of Tg-SwDI mice. Representative photomicrographs were taken from the thalamus. Scale bar = 10 μm. The values represent means ± SEM (N = 5 to 6). *P < 0.05, **P < 0.01.

Giselle F. Passos, et al. Am J Pathol. 2013 May;182(5):1740-1749.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center